Gray platelet syndrome: Proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice

  • J.A. Guerrero
  • , C. Bennett
  • , L. Van Der Weyden
  • , H. Mckinney
  • , M. Chin
  • , P. Nurden
  • , Z. Mcintyre
  • , E.L. Cambridge
  • , J. Estabel
  • , H. Wardle-Jones
  • , A.O. Speak
  • , Wendy Erber
  • , A. Rendon
  • , W.H. Ouwehand
  • , C.J.G. Ghevaert

Research output: Contribution to journalArticlepeer-review

Abstract

© 2014 by The American Society of Hematology. NBEAL2 encodes a multidomain scaffolding protein with a putative role in granule ontogeny in human platelets. Mutations in NBEAL2 underlie gray platelet syndrome (GPS), a rare inherited bleeding disorder characterized by a lack of α-granules within blood platelets and progressive bone marrow fibrosis. We present here a novel Nbeal2-/- murine model of GPS and demonstrate that the lack of α-granules is due to their loss from platelets/mature megakaryocytes (MKs), and not by initial impaired formation. We show that the lack of Nbeal2 confers a proinflammatory phenotype to the bone marrow MKs, which in combination with the loss of proteins from α-granules drives the development of bone marrow fibrosis. In addition, we demonstrate that α-granule deficiency impairs platelet function beyond their purely hemostatic role and that Nbeal2 deficiency has a protective effect against cancer metastasis.
Original languageEnglish
Pages (from-to)3624-3635
JournalBlood
Volume124
Issue number24
DOIs
Publication statusPublished - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Gray platelet syndrome: Proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice'. Together they form a unique fingerprint.

Cite this